Arkema S.A. (ARKAF) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $65.28. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
Financials: revenue is $9.1B, -7.4%/yr average growth. Net income is $63M, growing at -51.4%/yr. Net profit margin is 0.7% (thin). Gross margin is 17.8% (-4.5 pp trend).
Balance sheet: total debt is $5.4B against $6.0B equity (Debt-to-Equity (D/E) ratio 0.89, moderate). Current ratio is 2.13 (strong liquidity). Debt-to-assets is 37.6%. Total assets: $14.2B.
Analyst outlook: 1 / 2 analysts rate ARKAF as buy (50%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 15/100 (Fail), Past 100/100 (Pass), Health 67/100 (Partial), Moat 37/100 (Fail), Future 40/100 (Partial), Income 30/100 (Fail).